Yu Xiao (肖燏)
@xiaoyucaly.bsky.social
48 followers 41 following 22 posts
Postdoctoral researcher in DeMON lab, Lund University | Machine learning | Alzheimer’s Disease pregression modeling | multimodality neuroimaging
Posts Media Videos Starter Packs
Reposted by Yu Xiao (肖燏)
shaoshiz.bsky.social
🚨Thrilled to share our latest work just published in @nature.com where we looked into the optimal fMRI scan time for brain-wide association studies (BWAS) 🧠⏱️! Full thread below👇:
bttyeo.bsky.social
1/11 Excited to share our @Naturestudy led by @leonooi.bsky.social @csabaorban.bsky.social @shaoshiz.bsky.social

AI performance is known to scale with logarithm of sample size (Kaplan 2020), but in many domains, sample size can be # participants or # measurements...

doi.org/10.1038/s415...
xiaoyucaly.bsky.social
How could we predict multiple neurodegenerative disease using just blood sample and a single model? Check out this incredible work by @anlijuncn.bsky.social ⬇️
xiaoyucaly.bsky.social
How does brain change functionally in AD and aging? Check out this cool work from @jorittmo.bsky.social
jorittmo.bsky.social
How does the brain reorganize in the context of age and AD?

Are functional changes in age and AD similar?

Are these changes dynamic across the age/AD spectrum?

We unpack these questions in a sample of N=973 with AD biomarkers

Preprint: tinyurl.com/ymv8s7h8

⬇️🧵

1/
Reposted by Yu Xiao (肖燏)
borismontreal.bsky.social
Preprint 🥳

"A unified imaging-histology framework for superficial white matter architecture studies in the human brain"

🧠 SMW key for brain structure-function links
🤔 understudied because of its complexity
💡 SMW mapping for histology & MRI
🌟 OA

📖 lnkd.in/ef8bGGrF

by Youngeun Hwang et al
Reposted by Yu Xiao (肖燏)
anlijuncn.bsky.social
Check out Xiaoyu’s fantastic work!!
xiaoyucaly.bsky.social
🧠New preprint! What drives tau, the pathological protein in AD, to spread?
We found that WHERE tau appears and HOW MUCH accumulates are governed by different mechanisms. Check it out:
www.biorxiv.org/content/10.1...

#MedSky #neuroskyence #neurosky #alzsky #compneuro #MRI #neuroimaging #neurology
www.biorxiv.org
Reposted by Yu Xiao (肖燏)
jorittmo.bsky.social
Really important and cool work by @xiaoyucaly.bsky.social! Congratulations!
xiaoyucaly.bsky.social
🧠New preprint! What drives tau, the pathological protein in AD, to spread?
We found that WHERE tau appears and HOW MUCH accumulates are governed by different mechanisms. Check it out:
www.biorxiv.org/content/10.1...

#MedSky #neuroskyence #neurosky #alzsky #compneuro #MRI #neuroimaging #neurology
www.biorxiv.org
Reposted by Yu Xiao (肖燏)
biofinder.bsky.social
‼️New preprint!
We are happy to share our latest work led by @teanijarv.bsky.social investigating why tau pathology in AD often accumulates more in one hemisphere of the brain than the other.

Check out 🔗https://biorxiv.org/content/10.1101/2025.04.15.648728v1 or dive into the details below👇
xiaoyucaly.bsky.social
Thank you! This would be really interesting to see, but now we haven’t got the chance to do
Reposted by Yu Xiao (肖燏)
biofinder.bsky.social
🧠Exciting new findings from a great collaboration between the BioFINDER study and the talented
@xiaoyucaly.bsky.social from @jwvogel.bsky.social group!! In their preprint, they show that tau presence and tau load are guided by unique brain mechanisms. Dive into the details here 👇
xiaoyucaly.bsky.social
🧠New preprint! What drives tau, the pathological protein in AD, to spread?
We found that WHERE tau appears and HOW MUCH accumulates are governed by different mechanisms. Check it out:
www.biorxiv.org/content/10.1...

#MedSky #neuroskyence #neurosky #alzsky #compneuro #MRI #neuroimaging #neurology
www.biorxiv.org
Reposted by Yu Xiao (肖燏)
jwvogel.bsky.social
I am so very proud announce my lab's first preprint!!

@xiaoyucaly.bsky.social delves into the mechanisms driving tau distribution:
* Tau sequence driven by connectivity dynamics
* Tau load driven by local factors

Check out her thread below
xiaoyucaly.bsky.social
🧠New preprint! What drives tau, the pathological protein in AD, to spread?
We found that WHERE tau appears and HOW MUCH accumulates are governed by different mechanisms. Check it out:
www.biorxiv.org/content/10.1...

#MedSky #neuroskyence #neurosky #alzsky #compneuro #MRI #neuroimaging #neurology
www.biorxiv.org
xiaoyucaly.bsky.social
🧵18/
Finally, thanks to the @biofinder.bsky.social team— Nicola Spotorno, Olof Strandberg, @aitchbi.bsky.social , @gsalvado.bsky.social, Erik Stomrud, Ruben Smith, Sebastian Palmqvist, @rikossenkoppele.bsky.social, Niklas Mattsson-Carlgren, and Oskar Hansson—for sharing the awesome data and support.
xiaoyucaly.bsky.social
🧵17/
Thanks to Thomas Funck and Nicola Palomero-Gallagher for adding key receptor insights.
xiaoyucaly.bsky.social
🧵16/
We’re deeply grateful to @misicbata.bsky.social, @alaindagher.bsky.social, Justine Hansen, @vincebaz.bsky.social, and @goloafs.bsky.social for providing essential brain connectome and biological datasets; and for their guidance with the SIR model.
xiaoyucaly.bsky.social
🧵15/ Huge thanks to our amazing team and coauthors!

Endless thanks to @jwvogel.bsky.social for guiding and supporting this work from day one. To our amazing team DeMON lab, especially @anlijuncn.bsky.social for enormous support.
xiaoyucaly.bsky.social
🧵13/ Why does this matter? 4⃣
Most importantly, we believe this distinction should shape how we study tau going forward: ⚪️presence and 🔴load likely need to be studied using different tools and at different scales—but both are essential to fully understand and stop tau progression.
xiaoyucaly.bsky.social
🧵12/ Why does this matter? 3⃣
We also highlight 🎯neurotransmission marker dynamics as an underexplored yet promising direction for future research. Our findings point to the possibility of tau accumulating over a descending gradient of ionotropic excitatory potential.
xiaoyucaly.bsky.social
🧵11/ Why does this matter? 2⃣
Our model shows they stem from distinct neural mechanisms: ⚪️presence is shaped by structural connectivity and neurotransmitter architecture, whereas 🔴load is driven by local biological vulnerability.
xiaoyucaly.bsky.social
🧵10/ Why does this matter? 1️⃣
Today, Braak staging describes tau progression based on tau presence, while in vivo imaging and clinical trials typically assess tau load via PET. These are not equivalent measures.
xiaoyucaly.bsky.social
🧵9/ (Cont.) We identified two (of the four subtypes) with especially interesting mechanisms:

🔷Posterior subtype: Linked strongly to acetylcholine—already a treatment target!
🔷MTL-sparing subtype: Spread better explained by specific *functional* brain networks.
xiaoyucaly.bsky.social
🧵7/ What drives 🔴Tau Load? — Determined by connectivity and local biological factors

Connectivity isn’t enough—local vulnerability is key. Factors such as regional amyloid-beta levels, MAPT expression, cerebral blood flow, and neurotransmission markers profiles all play a role.
xiaoyucaly.bsky.social
🧵6/ Surprisingly, the balance of neurotransmission signals 🎯 (excitatory vs. inhibitory) and 5-HT receptors strongly overlap with tau presence. Regions with more ionotropic excitatory signaling are particularly vulnerable—supporting work focusing on E:I balance in AD.
xiaoyucaly.bsky.social
🧵5/ What drives ⚪️Tau Presence? — Primarily brain connectivity

As expected, tau follows structural connectivity. But unexpectedly, we also found 🎯neurotransmitter marker distribution does an even better job explaining the pattern. We found this fascinating and explored further.
xiaoyucaly.bsky.social
🧵4/ We next conducted an exploratory analysis using eight types of normative connectomes and 49 regional biological factors (thanks to @misicbata.bsky.social, his team, and the Allen Human Brain Atlas).